A Fortune 500 company, in conjunction with IBM Watson Health, conducted an economic evaluation to test whether our flagship digital therapeutic for insomnia, Sleepio, would lower health care costs for their employees.
Individuals who used Sleepio had 28% lower annualized total healthcare costs compared to those who did not use Sleepio — demonstrating $1,677 lower health care costs per employee that used Sleepio.
A peek inside:
Here’s our latest
How a Fortune 50 retailer lowered health care costs by nearly 20% with Sleepio for insomnia
The new health economic research report by a Johns Hopkins professor shows use of a digital therapeutic lowers overall healthcare…
The state of mental health equity
Insights from clinical experts focused on improving mental health disparities.
The impact of good mental health in the health care industry
If you’re looking for health care specific data to make the case for investing in employee mental health, you’ve come…
